Precision Medicine for Prostate Cancer — AI can help...
The multimodal ArteraAI Prostate Testopens in a new tab or window (AI Test) is currently the only test that provides insights [...]
An Artificial Intelligence–Digital Pathology Algorithm Predicts Survival After Radical...
Clinical variables alone have limited ability to determine which patients will have recurrence after radical prostatectomy (R [...]
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker...
A multimodal artificial intelligence (MMAI) biomarker was developed using clinical trial data from North American men with lo [...]
Diagnexia and Artera Partner to Bring Groundbreaking AI Prostate...
Diagnexia, the UK’s leading provider of AI-powered digital pathology diagnostic services, is thrilled to announce an exclusiv [...]
The 4 step process to achieve AI data locality...
As part of Artera’s mission to improve patient outcomes globally, Artera launched a highly successful product for patients wi [...]
Artera Product Webinar – February
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch th [...]
5 Common Myths That Accompany a Cancer Diagnosis
Receiving a cancer diagnosis can be the most terrifying moment of your life. It may feel as though your world is caving in ar [...]
Tempus Partners with Artera to Expand Personalized Prostate Cancer...
Tempus, a leader in using artificial intelligence (AI) to advance precision medicine connected to over half of all practicing [...]